COVID-19 Vaccine Accountability Act
This bill excludes manufacturers of a mandated COVID-19 vaccine from certain liability protections that apply to manufacturers of medical countermeasures (i.e., medical products that may be used to treat, prevent, or diagnose conditions associated with emerging infectious diseases or chemical, biological, radiological, or nuclear agents). It also retroactively limits to $10,000 the liability of the United States for a death or injury caused by a COVID-19 vaccine administered on or after January 1, 2020.
To amend title III of the Public Health Service Act to eliminate 
    immunity for manufacturers of COVID-19 vaccines, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Vaccine Accountability 
Act''.

SEC. 2. LIABILITY OF COVID-19 VACCINE MANUFACTURERS.

    (a) Covered Countermeasure.--Section 319F-3(i)(1) of the Public 
Health Service Act (42 U.S.C. 247d-6d(i)(1)) is amended by adding at 
the end the following:
                ``Such term does not include vaccines for COVID-19 that 
                are required (directly or as a condition of employment, 
                schooling, or otherwise) under Federal, State, or local 
                law to be administered to individuals eligible to 
                receive such a vaccine.''.
    (b) Covered Person.--Section 319F-3(i)(2) of the Public Health 
Service Act (42 U.S.C. 247d-6d(i)(2)) is amended by adding at the end 
the following:
                ``Such term does not include a manufacturer of a 
                vaccine described in the matter following subparagraph 
                (D) of paragraph (1).''.
    (c) Limitation of Liability.--Section 319F-3 of the Public Health 
Service Act (42 U.S.C. 247d-6d) is amended by adding at the end the 
following:
    ``(j) Limitation on Liability.--Pursuant to, and consistent with, 
the sovereign immunity reservation specified in subsection (f), the 
liability of the United States for a death or injury caused by the 
administration of a vaccine for COVID-19 occurring on or after January 
1, 2020 shall not exceed $10,000.''.
                                 <all>
COVID–19 Vaccine Accountability Act
To amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID-19 vaccines, and for other purposes.
COVID–19 Vaccine Accountability Act
Rep. Perry, Scott